Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness
Ya‐Chu Tsai, Tsen‐Fang Tsai
Therapeutic Advances in Musculoskeletal Disease (2017) Vol. 9, Iss. 11, pp. 277-294
Open Access | Times Cited: 116

Showing 1-25 of 116 citing articles:

Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
Kamran Ghoreschi, Anna Balato, Charlotta Enerbäck, et al.
The Lancet (2021) Vol. 397, Iss. 10275, pp. 754-766
Closed Access | Times Cited: 404
The Immunobiology of the Interleukin-12 Family: Room for Discovery
Elia D. Tait Wojno, Christopher A. Hunter, Jason S. Stumhofer
Immunity (2019) Vol. 50, Iss. 4, pp. 851-870
Open Access | Times Cited: 378
The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis
Teruki Dainichi, Akihiko Kitoh, Atsushi Otsuka, et al.
Nature Immunology (2018) Vol. 19, Iss. 12, pp. 1286-1298
Closed Access | Times Cited: 311
The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis
Michael P. Schön, Luise Erpenbeck
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 211
Role of regulatory T cells in psoriasis pathogenesis and treatment
Lea Nußbaum, You-Yue Chen, Graham S. Ogg
British Journal of Dermatology (2020) Vol. 184, Iss. 1, pp. 14-24
Open Access | Times Cited: 197
Current Developments in the Immunology of Psoriasis.
Franziska Grän, Andreas Kerstan, Edgar Serfling, et al.
The Yale Journal of Biology and Medicine (2020) Vol. 93, Iss. 1, pp. 97-110
Closed Access | Times Cited: 173
Skin Barrier Dysregulation in Psoriasis
Andreas Orsmond, Lara Bereza-Malcolm, Tom Lynch, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10841-10841
Open Access | Times Cited: 129
Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis
Satoshi Nakamizo, Charles‐Antoine Dutertre, Ahad Khalilnezhad, et al.
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 9
Open Access | Times Cited: 104
Treatment Options and Goals for Patients with Generalized Pustular Psoriasis
James G. Krueger, L. Puig, Diamant Thaçi
American Journal of Clinical Dermatology (2022) Vol. 23, Iss. S1, pp. 51-64
Open Access | Times Cited: 95
Interleukin-36 in Infectious and Inflammatory Skin Diseases
Anna-Lena Buhl, Joerg Wenzel
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 99
Interleukin 30 to Interleukin 40
Jovani Catalán-Dibene, Laura L. McIntyre, Albert Zlotnik
Journal of Interferon & Cytokine Research (2018) Vol. 38, Iss. 10, pp. 423-439
Open Access | Times Cited: 88
Cytokines in psoriasis
Camila C. De Alcantara, Edna Maria Vissoci Reiche, Andréa Name Colado Simão
Advances in clinical chemistry (2020), pp. 171-204
Closed Access | Times Cited: 74
Emerging roles for IL-11 in inflammatory diseases
Ka Yee Fung, Cynthia Louis, Riley D. Metcalfe, et al.
Cytokine (2021) Vol. 149, pp. 155750-155750
Open Access | Times Cited: 71
Key Signaling Pathways in Psoriasis: Recent Insights from Antipsoriatic Therapeutics
Hakim Ben Abdallah, Claus Johansen, Lars Iversen
Psoriasis Targets and Therapy (2021) Vol. Volume 11, pp. 83-97
Open Access | Times Cited: 58
Calcium/calmodulin-dependent protein kinase IV promotes imiquimod-induced psoriatic inflammation via macrophages and keratinocytes in mice
Yong Liang, Yafen Yu, Bao Li, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 50
Overlapping Features of Psoriasis and Atopic Dermatitis: From Genetics to Immunopathogenesis to Phenotypes
Ya‐Chu Tsai, Tsen‐Fang Tsai
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5518-5518
Open Access | Times Cited: 48
Epigenetic Dysregulation in Autoimmune and Inflammatory Skin Diseases
Frederick Gibson, Ailish Hanly, Nicole Grbic, et al.
Clinical Reviews in Allergy & Immunology (2022) Vol. 63, Iss. 3, pp. 447-471
Closed Access | Times Cited: 41
IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential
Marie‐Astrid Boutet, Alessandra Nerviani, Costantino Pitzalis
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1257-1257
Open Access | Times Cited: 73
Clinical and Genetic Heterogeneity of CARD14 Mutations in Psoriatic Skin Disease
Laura Israël, Mark Mellett
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 65
Interleukin-17: Friend or foe in organ fibrosis
Kritika Ramani, Partha S. Biswas
Cytokine (2019) Vol. 120, pp. 282-288
Open Access | Times Cited: 55
Malate enhances survival of zebrafish against Vibrio alginolyticus infection in the same manner as taurine
Manjun Yang, Di Xu, Dai-xiao Yang, et al.
Virulence (2020) Vol. 11, Iss. 1, pp. 349-364
Open Access | Times Cited: 53
IL-22 Binding Protein (IL-22BP) in the Regulation of IL-22 Biology
Lauren A. Zenewicz
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 44
Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action
Aina Akmal Mohd Noor, Maryam Azlan, Norhanani Mohd Redzwan
Biomedicines (2022) Vol. 10, Iss. 2, pp. 498-498
Open Access | Times Cited: 33
Autoinflammatory Disorders: A Review and Update on Pathogenesis and Treatment
Annika Havnaer, George Han
American Journal of Clinical Dermatology (2019) Vol. 20, Iss. 4, pp. 539-564
Closed Access | Times Cited: 51
Switching biologics in psoriasis - practical guidance and evidence to support
Ya‐Chu Tsai, Tsen‐Fang Tsai
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 5, pp. 493-503
Closed Access | Times Cited: 47
Page 1 - Next Page

Scroll to top